Table 1 Patient characteristics

From: Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

  

(%)

Mean age (range) years

59.4 (37–83)

 

Male/female

35/5

 

T stage

 T1

7

17.5

 T2

5

12.5

 T3

23

57.5

 T4

5

12.5

Grade

 1

9

22.5

 2

26

65.0

 3

5

12.5

Histological type

 Clear cell

38

95.0

 Papillary

2

5.0

Metastatic site

 Lung (lung mets only)

30 (18)

 

 Other site

22

 

Treatment

 IFN-α

15

37.5

 IFN-α+5FU

5

12.5

 IFN-γ

8

20.0

 IL-2

4

10.0

 IL-2+IFN-α+TU

8

20.0

  1. 5FU=5-fluorouracil; IFN=interferon; IL=interleukin; TU=tegafur uracil.
Back to article page